To this end, we leveraged gene-trait molecular networks previously elucidated by Mostafavi and colleagues (5) linking AD-associated transcriptomic patterns to disease-relevant end points (e.g., β-amyloid burden or cognitive decline) and assessed their interaction with CREB3L2-ATF4. This evidence concerns the gene CREB3L2 and Alzheimer disease.